References
- Mellstedt H. For The Myeloma Group of Central Sweden. 1990 MP versus MP/IFN-alpha induction theapy: a randomized trial in multiple myeloma. V Hannover Interferon Workshop 21–23.2. 44, 1990
- Mandelli F., Avvisati G., Amadori S., Boccadoro M., Gernone A., Lauta V. M., Marmont F., Petrucci M. T., Tribalto M., Vegna M. L., Dammacco F., Pileri A. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy. New England Journal of Medicine 1990; 322: 1430–1434
- Cooper M. R. Interferons in the management of multiple myeloma. Seminars in Oncology 1988; 15: 21–25, Suppl. 5
- Costanzi J. J., Pollard R. B. The use of interferon in the treatment of multiple myeloma. Seminars in Oncology 1987; 14: 24–28, Suppl. 2
- Selbach J., Purea H., Westerhausen M. Interferon alpha-2B with chemotherapy in advanced or refractory multiple myeloma. Blut 1989; 59: 326
- McGinnes K., Penny R. Effects of interferon on the in vitro synthesis of paraprotein by plasma cells in myeloma. Acta Hematologica 1988; 79: 72–76
- Tanaka H., Tanabe O., Iwato K., Asaoku H., Ishikawa H., Nobuyoshi M., Kawano M., Kuramoto A. Sensitive inhibitory effect of interferon-alpha on M-protein secretion of human myeloma cells. Blood 1989; 74: 1718–1722
- Duclos B., Bergerat J. P., Dufourt P., Godefroy W. Y., Damonte J. C., Oberling F. The combination of interferon alpha 2a (Roferon-A) and melphalan for refractory multiple myeloma. International Congress on Interferons in Oncology, Hanasaari. Espoo, Finland abstract 1988; 16–17
- Durie B. G., Dalton W. S. Reversal of drug-resistance in multiple myeloma with verapamil. British Journal of Haematology 1988; 68: 203–206
- Ma D. D. F., Scurr R. D., Davey R. A., Mackertich S. M., Harman D. H., Dowden G., Isbister J. P., Bell D. R. Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia. Lancet 1987; ii: 135–137
- Kato S., Nishimura J., Muta K., Yufu Y., Nawata H., Ideguchi H. Overexpression of P-glycoprotein in adult T-cell leukaemia. Lancet 1990; i: 573